REG - Treatt PLC - Director/PDMR Shareholding

TreattAnnouncement

19/05/2020 16:50

RNS Number : 3971N
  
Treatt PLC
  
19 May 2020
  
 

19 May 2020
TREATT PLC
("Treatt" or "the Company")
Notification of Transactions of Directors
In accordance with the requirements of the EU Market Abuse Regulation, the Company was notified on 19 May 2020 that on 15 May 2020, Richard Illek, Non-Executive Director, sold a total of 32,000 ordinary shares of the Company at an average price of £5.04 per ordinary share.
 



1


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Richard Illek




2


Reason for the notification




a)
 
 


Position/status


Non-Executive Director




b)


Initial notification/Amendment


 Initial Notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


 Treatt Plc




b)


LEI


 213800G40JM9F7G9LG39




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument
Identification code


Ordinary shares of 2 pence each
GB00BKS7YK08




b)


Nature of transaction


Sale of ordinary shares 
 
 
 




c)


Price(s) and volume(s)


Price(s)


Volume(s)












£5.06
£5.06
£5.04
£5.04
£5.04
£5.04
£5.04
£5.04
£5.04
£5.04
£5.04
£5.04
£5.04
£5.0668
 


750
765
391
609
97
903
1,000
7,485
2,205
2,000
2,000
1,795
2,000
10,000
 








Aggregated information
-      Aggregated volume
-      Price
 


 
32,000
£5.04
 




e)


Date of the transaction


15 May 2020
 




f)


Place of the transaction


London Stock Exchange, XLON



 
Contact details
Anita Guernari
Company Secretary
++ 44 1284 770028
END


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
DSHBUGDULSBDGGC